Altered cholesterol biosynthesis causes precocious neurogenesis in the developing mouse forebrain.

Area of Science:

• Developmental biology
• Neuroscience
• Genetics

Background:

• A mutation in hydroxysteroid (17-beta) dehydrogenase 7 (Hsd17b7) causes embryonic forebrain dysgenesis.
• Cholesterol biosynthesis is crucial for proper embryonic development.

Purpose of the Study:

• To investigate the impact of Hsd17b7 mutation on neuroprogenitor proliferation and cortical differentiation.
• To explore therapeutic interventions for Hsd17b7-associated developmental abnormalities.

Main Methods:

• Analysis of neuroprogenitor proliferation patterns in mutant embryos (E11.5-E14.5).
• In vitro primary neuron culture to assess cortical differentiation.
• In utero administration of statin and dietary cholesterol.

Main Results:

• Hsd17b7 mutation leads to decreased ventricular zone mitotic cells and altered interkinetic nuclear migration.
• Increased intermediate progenitors and expanded post-mitotic neurons observed in mutants.
• In utero treatment partially reversed forebrain developmental abnormalities.

Conclusions:

• Abnormally increased cholesterol precursors due to Hsd17b7 mutation disrupt neurogenesis, causing cortical dysgenesis.
• Targeting cholesterol metabolism may offer therapeutic strategies for developmental brain disorders.